235 related articles for article (PubMed ID: 32349254)
1. Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.
van der Houwen T; van Laar J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349254
[TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of Behçet's disease and treatment modalities.
van der Houwen TB; van Hagen PM; van Laar JAM
Semin Arthritis Rheum; 2022 Feb; 52():151956. PubMed ID: 35038644
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
4. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production profile in patients with Behcet's disease treated with infliximab.
Misumi M; Hagiwara E; Takeno M; Takeda Y; Inoue Y; Tsuji T; Ueda A; Nakamura S; Ohno S; Ishigatsubo Y
Cytokine; 2003 Dec; 24(5):210-8. PubMed ID: 14596817
[TBL] [Abstract][Full Text] [Related]
6. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
7. A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.
Watanabe S; Aizawa-Yashiro T; Tsuruga K; Kinjo M; Ito E; Tanaka H
Rheumatol Int; 2013 Dec; 33(12):3105-8. PubMed ID: 23266507
[TBL] [Abstract][Full Text] [Related]
8. Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
van der Houwen TB; van Hagen PM; Timmermans WM; Bartol SJ; Lam KH; Kappen JH; van Zelm MC; van Laar JA
Rheumatology (Oxford); 2017 Jan; 56(1):134-144. PubMed ID: 27744360
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
Yong C; Dan L; Chenhong L; Yan S; Jianfei C; Jianlong G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):127-133. PubMed ID: 30890498
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
12. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
13. [Effect of tripterygium glycosides on serum interleukin-1beta, interleukin-2, tumor necrosis factor alpha, and interferon-gamma levels in patients with Behcet's disease].
Song Q; Lu JZ; Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):598-600. PubMed ID: 20815274
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
16. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
17. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.
Mege JL; Dilsen N; Sanguedolce V; Gul A; Bongrand P; Roux H; Ocal L; Inanç M; Capo C
J Rheumatol; 1993 Sep; 20(9):1544-9. PubMed ID: 8164212
[TBL] [Abstract][Full Text] [Related]
19. Biological treatments in Behçet's disease: beyond anti-TNF therapy.
Caso F; Costa L; Rigante D; Lucherini OM; Caso P; Bascherini V; Frediani B; Cimaz R; Marrani E; Nieves-Martín L; Atteno M; Raffaele CG; Tarantino G; Galeazzi M; Punzi L; Cantarini L
Mediators Inflamm; 2014; 2014():107421. PubMed ID: 25061259
[TBL] [Abstract][Full Text] [Related]
20. Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease.
Palizgir MT; Akhtari M; Mahmoudi M; Mostafaei S; Rezaiemanesh A; Shahram F
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):297-302. PubMed ID: 29806793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
